Product
Iron Carboxymaltose
2 clinical trials
5 indications
Indication
Congestive Heart FailureIndication
systolicIndication
Iron DeficiencyIndication
hypophosphatemiaIndication
Roux-en-Y Gastric BypassClinical trial
Effect of Combination of Intravenous Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Patients With Heart Failure and Iron Deficiency.Status: Not yet recruiting, Estimated PCD: 2026-05-24
Clinical trial
Intravenous Iron-induced Hypophosphatemia in Patients With Roux-en-Y Gastric Bypass: a Single-blind, Randomized Clinical Trial Comparing Iron Isomaltoside (Monofer®) and Ferric Carboxymaltose (Ferinject®)Status: Not yet recruiting, Estimated PCD: 2026-06-01